Article

Dr. Boorady appointed COO of Eyemaginations

Towson, MD-Eyemaginations Inc. announced the appointment of Joseph Boorady, OD, as chief operating officer. Dr. Boorady joins Eyemaginations from his previous position as vice president for clinical affairs and executive director of the University Optometric Center at the SUNY College of Optometry, New York.

Towson, MD-Eyemaginations Inc. announced the appointment of Joseph Boorady, OD, as chief operating officer. Dr. Boorady joins Eyemaginations from his previous position as vice president for clinical affairs and executive director of the University Optometric Center at the SUNY College of Optometry, New York.

Dr. Boorady will be responsible for key business development initiatives as well as day-to-day operations, with his primary focus on developing and enhancing the infrastructure of a company experiencing dramatic expansion. He will work closely with Eyemaginations' Jeff Peres, president and chief executive officer, in developing strategy, identifying new markets, and maintaining unique content to solidify further the company's position as a market leader.

At SUNY, Dr. Boorady was responsible for a multimillion dollar enterprise, more than 400 employees, and the care of more than 150,000 patient visits per year. Additionally, he helped implement paperless electronic health records in 100-plus exam rooms.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.